This site is intended for healthcare professionals only
LoginRegister
CDSCO panel directs SII to submit safety and immunogenicity data for TB vaccineCDSCO panel directs SII to submit safety and immunogenicity data for TB vaccine
Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial for 2-18 age groupBharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial for 2-18 age group
Novavax seeks UK nod for Nuvaxovid use in adolescents aged 12 through 17 yearsNovavax seeks UK nod for Nuvaxovid use in adolescents aged 12 through 17 years
Journal Club - Antibiotics in children below 2 years to cause low vaccine responseJournal Club - Antibiotics in children below 2 years to cause low vaccine response
Supreme Court Upholds TelanganaSC finds no haste in granting EUA to covishield, covaxin
Antibiotics use in children below 2 years tied to reduced vaccine response: StudyAntibiotics use in children below 2 years tied to reduced vaccine response: Study
NTAGI panel recommends Sputnik V first dose as precautionary doseNTAGI panel recommends Sputnik V first dose as precautionary dose
USFDA VRBPA committee to review Novavax COVID vaccineUSFDA VRBPA committee to review Novavax COVID vaccine
COVID-19: WHO backed vaccine resolution wins 24 percent support at ModernaCOVID-19: WHO backed vaccine resolution wins 24 percent support at Moderna
SII Covovax inclusion in vaccination drive for 12-17 age group recommended by NTAGI panelSII Covovax inclusion in vaccination drive for 12-17 age group recommended by NTAGI panel
Govt to soon decrease gap between 2nd dose of Covid vaccine and booster dose to 6 monthsGovt to soon decrease gap between 2nd dose of Covid vaccine and booster dose to 6 months
Moderna seeks USFDA emergency use nod for COVID vaccine in children younger than 6Moderna seeks USFDA emergency use nod for COVID vaccine in children younger than 6
X